SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-011540
Filing Date
2020-10-19
Accepted
2020-10-19 08:57:01
Documents
14
Period of Report
2020-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20201019x8k.htm   iXBRL 8-K 44355
2 EX-99.1 imgn-20201019xex99d1.htm EX-99.1 18247
3 GRAPHIC imgn-20201019xex99d1001.jpg GRAPHIC 5023
  Complete submission text file 0001558370-20-011540.txt   195649

Data Files

Seq Description Document Type Size
4 EX-101.SCH imgn-20201019.xsd EX-101.SCH 2988
5 EX-101.LAB imgn-20201019_lab.xml EX-101.LAB 16757
6 EX-101.PRE imgn-20201019_pre.xml EX-101.PRE 9904
7 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20201019x8k_htm.xml XML 4692
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 201245346
SIC: 2834 Pharmaceutical Preparations